Umukandara n'umuhanda: Ubufatanye, Ubwumvikane na Win-Win
ibicuruzwa

Ibicuruzwa

Tirzepatide CAS: 2023788-19-2 Utanga ibicuruzwa

Tirzepatide yatejwe imbere nka agonisti ebyiri kuri GLP-1 hamwe na gastric inhibitory polypeptide (GIP) yakira (Frias et al., 2018).Kimwe na GLP-1, GIP ni imisemburo ya incretin ikora mu gutera insuline. .Irimo kwigwa kandi nk'ubuvuzi bushobora kuvura indwara ya steatohepatite idafite inzoga (NASH) no kunanirwa k'umutima hamwe n'uduce duto two gusohora (HFpEF).


Ibicuruzwa birambuye

Ibicuruzwa

Gushyira mu bikorwa n'ingaruka

Tirzepatide ikoreshwa hamwe nimirire ikwiye hamwe na gahunda yo gukora siporo kugirango igabanye isukari nyinshi mu maraso ku bantu barwaye diyabete yo mu bwoko bwa 2.Kugenzura isukari nyinshi mu maraso bifasha kwirinda kwangirika kwimpyiko, ubuhumyi, ibibazo byimitsi, gutakaza ingingo, nibibazo byimikorere yimibonano mpuzabitsina. ya hyperglycemia ugereranije na GLP-1 yakira reseptor agonist.Ubushakashatsi bwerekana ibimenyetso bwerekanye ko ibyo biterwa na tirzepatide yigana ibikorwa bya GIP karemano kuri reseptor ya GIP.

Icyitegererezo cyibicuruzwa

20 420 (1)
20 320 (1)

Gupakira ibicuruzwa:

8 338 (1)

Amakuru yinyongera:

Ibigize Na
Suzuma 99%
Kugaragara Ifu yera
URUBANZA No. 2023788-19-2
Gupakira 25KG
Ubuzima bwa Shelf Imyaka 2
Ububiko Ubike ahantu hakonje kandi humye
Icyemezo ISO.

  • Mbere:
  • Ibikurikira:

  • Andika ubutumwa bwawe hano hanyuma utwohereze